AGENCIES, New Delhi: US President Donald Trump said that he has requested Prime Minister Narendra Modi to release the anti-malarial drug hydroxychloroquine to treat COVID-19 patients.
“After call with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine,” Trump said, reported NDTV. Trump and Modi had a telephonic conversation over the coronavirus pandemic on Saturday. Modi tweeted about it on Saturday and wrote, “Had an extensive telephone conversation with President @realDonaldTrump We had a good discussion, and agreed to deploy the full strength of the India-US partnership to fight COVID-19.”
“India makes a lot of it. They need a lot too for their billion-plus people. The hydroxychloroquine, the anti-malaria drug will be released through the Strategic National Stockpile for treatment,” he said.
India had banned the export of the drug after the COVID-19 outbreak in the country.
Decades old malaria-drug hydroxychloroquine appears to have some good results in the treatment of coronavirus patients, Trump said.
“We continue to study the effectiveness of hydroxychloroquine and other therapies in the treatment and prevention of the virus and will keep the American people fully informed in our findings,” Trump told reporters during a press briefing at the White House.
Trump said that it looked as if hydroxychloroquine is having some good results.
“It’s looking like it (hydroxychloroquine) is having some good results. I hope that would be a phenomenal thing,” Trump said, days after the US Federal and Drug Administration approved the drug being used in the treatment of coronavirus (COVID-19) patients.
Meanwhile, the US president has said he will not wear a face mask despite new medical guidance advising Americans to do so, reported BBC.